Target intelligence / Profile preview

DSCAM intronic transcript 1 (DSCAM-IT1)

Target: DSCAM-IT1
Molecular classification: lncRNA, non-protein coding RNA

Overview

DSCAM intronic transcript 1 (DSCAM-IT1) is annotated as a long non-coding RNA deriving from the intronic regions of the DSCAM gene. Its specific sequence, expression profile, and biological function in human or model organisms have not been characterized in the published literature. Its identity is distinct from DSCAM protein (an axon guidance receptor critical in neural development[1][3][5]) and from DSCAM-AS1, a well-studied lncRNA implicated in cancer biology through microRNA sponging and regulatory mechanisms[2][4]. There is currently insufficient evidence to consider DSCAM-IT1 a validated therapeutic target, biomarker, or actively studied molecular entity.

Other names: zag4DSCAM intronic transcript 1 (non-protein coding)

Beyond the preview

Go deeper on DSCAM intronic transcript 1 (DSCAM-IT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSCAM intronic transcript 1 (DSCAM-IT1).

Explore the full profile